Side by side with Genzyme's commitment to patients is our commitment to the health care professionals who treat and care for them. Please reach out to us if you have any questions or concerns.
Genzyme Medical Information is staffed with experts in our products and the diseases they treat, who are available to answer your questions. In the U.S., you can call 800-745-4447 (toll-free) or 617-768-9000, and choose option #2, Monday through Friday between 8 a.m. and 6 p.m. (EST).
If you are outside the U.S. you can use your online form to send a message to Medical Information's regional contacts:
If you have a patient taking a Genzyme product who is experiencing side effects, please report this information to us by contacting Genzyme Medical Information - see above for phone numbers for the U.S. and links to our online form for other regions.
In the U.S., you are encouraged to report negative side effects of prescription drugs to the FDA via its MedWatch program:
Find out more about reporting side effects to Genzyme
Genzyme collaborates with and supports health care professionals in many ways, from co-sponsoring clinical trials to providing research and education grants.
Committed to Transparency
At Genzyme we are focused on making a difference in patients’ lives. To make tomorrow’s therapeutic solutions real, we seek to innovate with other individuals and organizations, who like us, aim to improve patient health. We work with physicians and teaching hospitals as well as patient associations and others involved in healthcare. We are fully committed to transparency; it is important to us to foster an understanding of these interactions and to prevent any real or perceived conflict of interest. As part of the federal Open Payments (Physician Payments Sunshine Act), overseen by the Centers for Medicare and Medicaid Services (CMS) any payment or transfer of value we make to a physician or teaching hospital is subject to collection and potential public reporting. These payments are separate and in addition to existing state transparency reporting requirements. We continue to be dedicated to complying with state and federal laws and regulations today and in the future.
Genzyme is a Sanofi company. See Sanofi's full Transparency statement
Genzyme is an industry leader in providing support services and programs to help patients obtain access to treatment, including help with understanding insurance plans, finding alternative forms of funding, and opportunities to obtain free or subsidized treatment.
Find out more about Genzyme's patient support services
You may also want to direct your patients to Genzyme.com to explore our educational information and resources.
Genzyme has established registries - large, often multinational databases to which physicians contribute clinical data on patients - for several lysosomal storage disorders (LSDs), to help pool knowledge and improve understanding of these rare diseases. Get more information and enroll patients online at the registries' websites:
Genzyme's specialized product portfolio addresses serious medical needs, including rare genetic diseases, through innovative, targeted treatments. To see our current product list and get quick access to Prescribing Information for each product, visit the product information page.
For our treatments approved in the U.S., the individual product websites are the best source for detailed information about the product itself, billing codes and reimbursement procedures, supporting services, and more.
Global Product Information
If you are outside the U.S., learn more about our products approved and marketed in your area by exploring the Genzyme website for your country or region.
View all Genzyme websites
Last Updated: 9/4/2015